Search

Home > Industry Focus > Healthcare: 3 Genomics Stocks Revolutionizing Healthcare And Why Alnylam's New Deal Didn't Excite Investors
Podcast: Industry Focus
Episode:

Healthcare: 3 Genomics Stocks Revolutionizing Healthcare And Why Alnylam's New Deal Didn't Excite Investors
Category: Business
Duration: 00:31:36
Publish Date: 2019-04-10 14:30:00
Description:

Here's why a $1 billion deal with Regeneron failed to spark a rally in Alnylam shares. Also, will genetic discovery be our generation's biggest trend? If so, Illumina, bluebird bio, and Invitae could be top stocks to watch.

Check out more of our content here:
Total Play: 0

Users also like

0 Episodes
MarketFooler .. 100+     6
700+ Episodes
Rule Breaker .. 200+     6
2K+ Episodes
Motley Fool .. 300+     10+

Some more Podcasts by The Motley Fool

300+ Episodes
Motley Fool ..    
700+ Episodes
Rule Breaker .. 200+     6
400+ Episodes
Motley Fool .. 100+     5
2K+ Episodes
Motley Fool .. 300+     10+
2K+ Episodes
Motley Fool ..